TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | -1 | 11 | 60 | 121 | 82 | 91 | 61 |
| P | %wins | 50 | 50 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/17/24 19:36 | 4/11/24 | BCEL | Atreca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | P | 0 | 0.0100 | 0 | 0 | 0 | 78 | D | ||||||||||||||
3/19/20 18:52 | 3/17/20 | BCEL | Atreca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | P | 77 | 12.79 | 0 | 6 | New | 6 | D | ||||||||||||||
2/17/16 19:50 | 2/12/16 | SGEN | Seattle Genetics Inc /wa | DE | Health | BioPrd | Biological Products, (No Diag | Orwin John A | WA | D | P | 57 | 28.33 | 33 | 2 | 23 | 11 | D | -40 | -3 | -30 | -28 | -27 | -18 | -7 | 14 | -6 | -7 | 3 | 9 | 51 | 102 | |
11/20/13 19:10 | 11/20/13 | RLYP | Relypsa Inc | Health | Drug | Pharmaceutical Preparations | Orwin John A | CA | DO | P,CEO | P | 165 | 11.00 | 12 | 15 | New | 15 | D | 5 | 29 | 117 | 233 | 112 | 80 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |